Detalhe da pesquisa
1.
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
Blood
; 127(18): 2214-8, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872634
2.
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Blood
; 128(7): 911-22, 2016 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229005
3.
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro.
J Enzyme Inhib Med Chem
; 28(2): 360-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23163664
4.
Exogenous and endogenous markers of tumour oxygenation status: definitive markers of tumour hypoxia?
Adv Exp Med Biol
; 566: 285-94, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16594164
5.
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.
PLoS One
; 9(10): e108107, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25279465
6.
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1.
Mol Pharmacol
; 69(2): 411-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16254058